Polyphosphate nanoparticles on the platelet surface trigger contact system activation

Blood

Volumn 129, Issue 12, 2017, Pages 1707-1717

  Verhoef, Johan J F ^a   Barendrecht, Arjan D ^b   Nickel, Katrin F ^c,d   Dijkxhoorn, Kim ^b   Kenne, Ellinor ^c   Labberton, Linda ^c   McCarty, Owen J T ^e   Schiffelers, Raymond ^b   Heijnen, Harry F ^b   Hendrickx, Antoni P ^b   Schellekens, Huub ^a   Fens, Marcel H ^b   De Maat, Steven ^b   Renné, Thomas ^c,d   Maas, Coen ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; KAOLIN; NANOPARTICLE; PHOSPHATE; POLYPHOSPHATE; PREKALLIKREIN; PROCOAGULANT;

ARTICLE; BLOOD CLOTTING; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; ULTRACENTRIFUGATION; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; METABOLISM; SECRETION (PROCESS); THROMBOCYTE; ULTRASTRUCTURE;

BLOOD COAGULATION; BLOOD PLATELETS; CELL MEMBRANE; FACTOR XII; HUMANS; NANOPARTICLES; POLYPHOSPHATES;

EID: 85016290107     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-08-734988     Document Type: Article

References (47)

1. Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem. 2004;279(43):44250-44257.
2. Moreno-Sanchez D, Hernandez-Ruiz L, Ruiz FA, Docampo R. Polyphosphate is a novel proinflammatory regulator of mast cells and is located in acidocalcisomes. J Biol Chem. 2012;287(34):28435-28444.
3. Nickel KF, Ronquist G, Langer F, et al. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis. Blood. 2015;126(11):1379-1389.
4. Montilla M, Hernández-Ruiz L, García-Cozar FJ, Alvarez-Laderas I, Rodríguez-Martorell J, Ruiz FA. Polyphosphate binds to human von Willebrand factor in vivo and modulates its interaction with glycoprotein Ib. J Thromb Haemost. 2012;10(11):2315-2323.
5. Brandt S, Krauel K, Jaax M, et al. Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria. Thromb Haemost. 2015;114(6):1189-1198.
6. Wijeyewickrema LC, Lameignere E, Hor L, et al. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor. Blood. 2016;128(13):1766-1776.
7. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA. 2006;103(4):903-908.
8. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood. 2011;118(26):6963-6970.
9. Choi SH, Smith SA, Morrissey JH. Polyphosphate accelerates factor V activation by factor XIa. Thromb Haemost. 2015;113(3):599-604.
10. Puy C, Tucker EI, Ivanov IS, et al. Platelet-derived short-chain polyphosphates enhance the inactivation of tissue factor pathway inhibitor by activated coagulation factor XI. PLoS One. 2016;11(10):e0165172.
11. Mutch NJ, Engel R, Uitte De Willige S, Philippou H, Ariëns R A S. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood. 2010;115(19):3980-3988.
12. Travers RJ, Shenoi RA, Kalathottukaren MT, Kizhakkedathu JN, Morrissey JH. Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis. Blood. 2014;124(22):3183-3190.
13. Zhu S, Travers RJ, Morrissey JH, Diamond SL. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow. Blood. 2015;126(12):1494-1502.
14. Labberton L, Kenne E, Long AT, et al. Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection. Nat Commun. 2016;7:12616.
15. Matafonov A, Leung PY, Gailani AE, et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood. 2014;123(11):1739-1746.
16. Revenko AS, Gao D, Crosby JR, et al. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood. 2011;118(19):5302-5311.
17. Yau JW, Liao P, Fredenburgh JC, et al. Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. Blood. 2014;123(13):2102-2107.
18. Renné T, Pozgajová M, Grüner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med. 2005;202(2):271-281.
19. Castaldi PA, Larrieu MJ, Caen J. Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature. 1965;207(995):422-424.
20. Walsh PN, Griffin JH. Platelet-coagulant protein interactions in contact activation. Ann N Y Acad Sci. 1981;370:241-252.
21. Johne J, Blume C, Benz PM, et al. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol Chem. 2006;387(2):173-178.
22. Bäck J, Sanchez J, Elgue G, Ekdahl KN, Nilsson B. Activated human platelets induce factor XIIamediated contact activation. Biochem Biophys Res Commun. 2010;391(1):11-17.
23. Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139(6):1143-1156.
24. Smith SA, Choi SH, Davis-Harrison R, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size [published correction appears in Blood. 2011;117(12):3477]. Blood. 2010;116(20):4353-4359.
25. Morrissey JH, Smith SA. Polyphosphate as modulator of hemostasis, thrombosis, and inflammation. J Thromb Haemost. 2015;13(Suppl 1):S92-S97.
26. Puy C, Tucker EI, Wong ZC, et al. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. J Thromb Haemost. 2013;11(7):1341-1352.
27. Holmsen H, Weiss HJ. Secretable storage pools in platelets. Annu Rev Med. 1979;30:119-134.
28. Fitch-Tewfik JL, Flaumenhaft R. Platelet granule exocytosis: a comparison with chromaffin cells. Front Endocrinol (Lausanne). 2013;4:77.
29. Donovan AJ, Kalkowski J, Smith SA, Morrissey JH, Liu Y. Size-controlled synthesis of granular polyphosphate nanoparticles at physiologic salt concentrations for blood clotting. Biomacromolecules. 2014;15(11):3976-3984.
30. Remijn JA, Wu YP, Ijsseldijk MJ, Zwaginga JJ, Sixma JJ, De Groot PG. Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions. Thromb Haemost. 2001;85(4):736-742.
31. Rouser G, Fkeischer S, Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 1970;5(5):494-496.
32. Summer H, Grämer R, Dröge P. Denaturing urea polyacrylamide gel electrophoresis (Urea PAGE). J. Vis. Exp. JoVE. 2009; (32)
33. Smith SA, Morrissey JH. Sensitive fluorescence detection of polyphosphate in polyacrylamide gels using 49, 6-diamidino-2-phenylindol. Electrophoresis. 2007;28(19):3461-3465.
34. De Maat S, Björkqvist J, Suffritti C, et al. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. J Allergy Clin Immunol. 2016;138(5):1414-1423. e9.
35. Nishibori M, Cham B, McNicol A, Shalev A, Jain N, Gerrard JM. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest. 1993;91(4):1775-1782.
36. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107(36):15880-15885.
37. Morrissey JH, Choi SH, Smith SA. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood. 2012;119(25):5972-5979.
38. Hernández-Ruiz L, Sáez-Benito A, Pujol-Moix N, Rodríguez-Martorell J, Ruiz FA. Platelet inorganic polyphosphate decreases in patients with delta storage pool disease. J Thromb Haemost. 2009;7(2):361-363.
39. Ghosh S, Shukla D, Suman K, et al. Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels. Blood. 2013;122(8):1478-1486.
40. Binas English Edition. Handbook for Physics, Chemistry, Biology and Mathematics. Groningen, The Netherlands: Wolters-Noordhoff; 2007.
41. Donovan AJ, Kalkowski J, Szymusiak M, et al. Artificial dense granules: a procoagulant liposomal formulation modeled after platelet polyphosphate storage pools. Biomacromolecules. 2016;17(8):2572-2581.
42. De Maat S, Maas C. Factor XII: form determines function. J Thromb Haemost. 2016;14(8):1498-1506.
43. Bock PE, Srinivasan KR, Shore JD. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Biochemistry. 1981;20(25):7258-7266.
44. Kunder CA, St John AL, Li G, et al. Mast cellderived particles deliver peripheral signals to remote lymph nodes. J Exp Med. 2009;206(11):2455-2467.
45. Cugno M, Marzano AV, Asero R, Tedeschi A. Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern Emerg Med. 2010;5(2):97-101.
46. Sala-Cunill A, Björkqvist J, Senter R, et al. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J Allergy Clin Immunol. 2015;135(4):1031-43. e6.
47. Oschatz C, Maas C, Lecher B, et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity. 2011;34(2):258-268.